Minsing Choi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
6083 Background: Colorectal cancer (CRC) is the second leading cause of death from cancer in United States. Overall survival (OS) for stage IV colon cancer has doubled to 20-24 months with the use of newer active chemotherapy and biologic agents in clinical trials. However there is no current data in population based setting how the biologics have impacted(More)
8548 Background: The percentage of cancer patients ≥ 80 years old is expected to rise in the United States. However data are limited on use of chemotherapy in this group of patients. METHODS Retrospective identification of patients who received systemic chemotherapy at our cancer center between 1/1/2000 to 12/31/2004 was performed using the computer(More)
PURPOSE Appendiceal mucinous neoplasms (AMN) are a rare heterogeneous group of diseases. In the absence of randomized trials, AMN management is controversial. The goal of this study was to evaluate the impact of hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery on survival in AMN patients. PATIENTS AND METHODS Patient data(More)
  • 1